AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New advances reported in treating reproductive consequences of other conditions.

Women's Health Weekly

| November 06, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 6 - (NewsRx.com & NewsRx.net) -- The impact on a patient's reproductive health is often a misunderstood part of treating their underlying medical condition.

Gathering at the annual meeting of the American Society for Reproductive Medicine, held October 11-15, 2003, physicians discussed new developments in helping those patients with the reproductive consequences of their conditions.

A prospective comparison of tamoxifen alone and tamoxifen-FSH combined protocol for IVF & fertility preservation in breast cancer patients. Researchers at Weill Medical College of Cornell University revealed the results of using tamoxifen or tamoxifen with follicle stimulating hormone (FSH) added to increase the chances of success when breast cancer survivors undergo assisted reproduction for either fertility preservation or treatment of infertility.

Because the chemotherapy for their cancer often leaves them infertile, patients need assisted reproductive technologies (ART) to cryopreserve their embryos in order to have children in the future. This treatment is also used for cancer survivors who are infertile after chemotherapy and need ART to conceive. However, many of the drugs used to stimulate egg production may be dangerous to cancer patients.

This study found that using the tamoxifen-FSH combination was a safe alternative to unstimulated cycles and resulted in a greater number of embryos than tamoxifen alone.

Fertility preservation using ART and embryo cryopreservation prior to chemotherapy in breast cancer patients: New and safe protocol for ovarian stimulation. Doctors in Ramat Gan, Israel, are working on ways to make ovarian stimulation safer for breast cancer patients who want to preserve fertility by undergoing ...

Related articles from newspapers, magazines, journals, and more
New Study Supports Dose-Dense Chemotherapy Regimen for Cancer Patients; Breast...
Press release article from: PR Newswire December 12, 2002 700+ words
...to chemotherapy can improve breast cancer patients' survival by compressing chemotherapy...study of 2,005 women with breast cancer, coordinated by the Cancer...BITES: Deborah Glickman, Breast Cancer Patient Who Received Dose...
FTD to Support Breast Cancer Patients During Breast Cancer Awareness Month in...
Press release article from: PR Newswire October 1, 2007 700+ words
...provider, is increasing its support for breast cancer patients during October's Breast Cancer Awareness Month by enhancing its product...information, empowerment and support for breast cancer patients and working to ensure that no one faces...
High frequency of skewed X inactivation in young breast cancer patients....
Magazine article from: Journal of Medical Genetics Langerod, A. Knudsen, G.P. Weber, B.L. Borresen-Dale, A-L Kristiansen, M. Orstavik, K.H. January 1, 2002 700+ words
...peripheral blood from 216 breast cancer patients. Methods: X inactivation...chromosome. Results: Young breast cancer patients (27-45 years) had a...inactivation analysis of 216 breast cancer patients. The androgen receptor...
Connection Cards(TM) Program from Aventis Provides Valuable Resources for...
Press release article from: PR Newswire September 3, 2002 700+ words
...program, a nationwide initiative to provide breast cancer patients with information on breast cancer resources. Now in its third year, the...needs of women undergoing treatment for breast cancer to connect with family and friends, speak...
Brain Screenings Offered to Breast Cancer Patients During Breast Cancer...
Press release article from: PR Newswire October 19, 2007 700+ words
...a clinical trial. HER2 is a breast cancer that tests positive for a protein...in as many as 30 percent of breast cancer patients have a metastasis in the brain...risk and/or HER-2 positive breast cancer. They must be at least 18 years...
DC-Area Brides Help Grant Wishes to Terminal Breast Cancer Patients; 'Brides...
News wire article from: The America's Intelligence Wire October 7, 2005 700+ words
...Local Brides Help Grant Wishes to Terminal Breast Cancer Patients -- "Brides Against Breast Cancer a Nationwide Tour of Gowns" -- 3rd Annual...to fulfilling wishes for terminally ill breast cancer patients, is holding the Washington area's third...
Lapatinib Shows Anti-Tumour Activity in Herceptin(R) - Resistant Breast Cancer...
Press release article from: PR Newswire June 6, 2004 700+ words
...estimated 40,580 will die from the disease. Breast cancer is the most common malignancy in women and...cancer death. Approximately 40 percent of breast cancer patients develop metastatic breast cancer (disease that has spread to other organs...
Important News for Breast Cancer Patients During National Breast Cancer...
Press release article from: PR Newswire October 7, 2005 700+ words
...More Than a Mammogram: Leading Breast Cancer Expert Tells Women What They...7 /PRNewswire/ -- NEWS: Breast Cancer Patients Need To Ask For Additional Tests...SUMMARY: October is national breast cancer awareness month, an important...
Survey: Breast Cancer Patients Say Primary Caregiver's Job Performance Not...
Press release article from: PR Newswire April 9, 2007 700+ words
...FirstCall/ -- Among breast cancer patients who identified partners...recurrent or metastatic breast cancer patients about the impact breast...recurrent or metastatic breast cancer patients was conducted online between...
FDA Approves Use of PathVysion(R) Breast Cancer Test to Select Appropriate...
Press release article from: PR Newswire January 10, 2002 700+ words
...the HER-2/neu gene in breast cancer patients received approval from the...medical oncologists and breast cancer patients in helping them obtain accurate...cells in 25 to 30 percent of breast cancer patients. HER-2 positive breast...
For more facts and information, see all results

Source: HighBeam Research, New advances reported in treating reproductive consequences of other...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA